Hepatoprotective effects and safety profile of donafenib combined with transarterial chemoembolization in unresectable hepatocellular carcinoma. This is an ASCO Meeting Abstract from the 2025 ASCO ...

LOS ALTOS, Calif.--(BUSINESS WIRE)--RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company focused on the localized treatment of difficult-to-treat solid tumors through its proprietary RenovoRx ...

Please provide your email address to receive an email when new articles are posted on . Glaucoma is the second leading cause of blindness in the U.S. A primary screening tool for glaucoma is ...

New Woodson Road location enhances access to comprehensive, hospital-free interventional pain, injury rehabilitation, ...